Telemetry Investments, L.L.C. Ionis Pharmaceuticals Inc Transaction History

Telemetry Investments, L.L.C.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$40.53 - $50.7 $274,793 - $343,746	-6,780 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$44.08 - $55.05 $298,862 - $373,239	6,780 New	6,780 $299,000
Q4 2017 Feb 14, 2018	SELL	$50.3 - $64.39 $310,854 - $397,930	-6,180 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$45.56 - $59.57 $281,560 - $368,142	6,180	6,180 $313,000

389

125M

2.25M

510K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.64B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Telemetry Investments, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Telemetry Investments, L.L.C. with notifications on news.